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Abstract
Background -: Genetic testing for hereditary colorectal cancer (HCRC) had significant psychological consequences for 
test recipients. This prospective longitudinal study investigated the factors that predict psychological resilience in 
adults undergoing genetic testing for HCRC.
Methods -: A longitudinal study was carried out from April 2003 to August 2006 on Hong Kong Chinese HCRC family 
members who were recruited and offered genetic testing by the Hereditary Gastrointestinal Cancer Registry to 
determine psychological outcomes after genetic testing. Self-completed questionnaires were administered 
immediately before (pre-disclosure baseline) and 2 weeks, 4 months and 1 year after result disclosure. Using validated 
psychological inventories, the cognitive style of hope was measured at baseline, and the psychological distress of 
depression and anxiety was measured at all time points.
Results -: Of the 76 participating subjects, 71 individuals (43 men and 28 women; mean age 38.9 ± 9.2 years) from nine 
FAP and 24 HNPCC families completed the study, including 39 mutated gene carriers. Four patterns of outcome 
trajectories were created using established norms for the specified outcome measures of depression and anxiety. 
These included chronic dysfunction (13% and 8.7%), recovery (0% and 4.3%), delayed dysfunction (13% and 15.9%) and 
resilience (76.8% and 66.7%). Two logistic regression analyses were conducted using hope at baseline to predict 
resilience, with depression and anxiety employed as outcome indicators. Because of the small number of participants, 
the chronic dysfunction and delayed dysfunction groups were combined into a non-resilient group for comparison 
with the resilient group in all subsequent analysis. Because of low frequencies, participants exhibiting a recovery 
trajectory (n = 3 for anxiety and n = 0 for depression) were excluded from further analysis. Both regression equations 
were significant. Baseline hope was a significant predictor of a resilience outcome trajectory for depression (B = -0.24, p 
< 0.01 for depression); and anxiety (B = -0.11, p = 0.05 for anxiety).
Conclusions -: The current findings suggest that hopefulness may predict resilience after HCRC genetic testing in 
Hong Kong Chinese. Interventions to increase the level of hope may be beneficial to the psychological adjustment of 
CRC genetic testing recipients.
Background
Although predictive genetic testing undertaken to iden-
tify mutated gene carriers for continued medical surveil-
lance is now possible [1-4], this procedure has important
psychological consequences. In a prior study, up to 43%
of adults who tested positive for familial adenomatous
polyposis (FAP) were clinically anxious after receiving
their genetic testing result [5]. In another study on recipi-
ents of BRCA1/2 or HNPCC genetic susceptibility test-
ing, 29.3% and 14.1% of participants showed an increase
in hereditary cancer-related distress levels at two weeks
and six months after test result disclosure, respectively
[6]. Other studies, in contrast, have reported that individ-
uals undergoing genetic testing did not experience
adverse psychological consequences [7]. Despite these
inconsistent findings, some studies have shown that car-
riers tend to exhibit at least a transient increase in their
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anxiety levels after disclosure [8]. Psychological distress
among mutation carriers is understandable because they
have to face the uncertainty of the onset of cancer, the
possibility of passing the faulty gene on to their children,
and the potential for genetic discrimination [9-15]. More-
over, test-related distress may have a negative effect on
compliance with health-protective behaviours [13]. Ho et
al provide indirect support for this proposition in a study
of 62 hereditary colorectal cancer (HCRC) genetic testing
recipients [10]. The researchers found that subjects with
higher depression level tended to focus more on the neg-
ative consequences of learning their genetic testing
results and hence may choose to decline genetic testing.
There is a need to identify the factors that affect resil-
ience to HCRC genetic testing so that appropriate inter-
vention can be provided to increase compliance and
improve the psychological well-being of those tested.
Hope and Coping with Cancer
Personal characteristics may have an important effect on
adjustment to HCRC genetic testing. Michie et al. [5]
concluded from a longitudinal prospective study that
HCRC genetic testing subjects who were low in optimism
and self-esteem were more likely to be clinically anxious
in the first year after testing. The cognitive theory of hope
proposed by Snyder and his colleagues [16,17] in helping
people to cope with stressors has recently been the focus
of much attention. According to this model, hope has
three interrelated cognitive components: goals, agency
and pathways. Agency refers to an individual's motivation
to meet desired goals, while pathways refer to an individ-
ual's ability to produce routes to attain these goals [18]. A
guiding assumption of Snyder's hope model is that
human actions are goal-directed [16] and goals them-
selves are the cognitive anchors of hopeful thinking [19].
Goals may vary in terms of their time frame (short- or
long-term), yet they have to be of sufficient value to the
individual to occupy conscious thought [20]. Goals typi-
cally contain some degree of uncertainty, yet they must
be  a t t a i n a b l e  [ 2 1 ] .  S n y d e r ' s  m od e l  p r o po s e s  t h a t  w h e n
confronted with negative events such as a positive genetic
testing result for HCRC, high-hope individuals will be
distressed only temporarily and will bounce back full of
energy and ideas on how to achieve their life goals [22].
Research shows that hope is a significant predictor of
psychological well-being not only among healthy people
[23] but also among individuals with chronic illnesses
such as spinal cord injuries [24] and cancer [25-28]. For
example, Stanton and colleagues [27] investigated hope
and coping strategies as predictors of adjustment among
85 women one year after a diagnosis of breast cancer and
reported that high-hope women adopting problem-
focused coping strategies adjusted better.
Prototypical Psychological Outcome Trajectories after a 
Stressful Event
Although HCRC genetic testing is a stressful event for
most people, there are marked differences in how individ-
uals respond to it [29]. Bonanno and his colleagues [30-
33] identified four prototypical patterns or trajectory out-
comes that capture most people's long-term psychologi-
cal responses after a potentially traumatic event. The four
trajectories are resilience, chronic dysfunction, recovery,
and delayed reaction [33].
Resilience is conceptualized as an individual's ability to
maintain a relatively stable and healthy level of psycho-
logical and physical functioning after a traumatic event
[31-35]. People in the chronic dysfunction category show
a consistent and persistent pattern of elevated symptoms
and distress. Typically, only a small percentage of individ-
uals (from 5% to 10%) exhibit this trajectory pattern, but
the percentage may vary according to the severity and
type of trauma [30]. Another prototypical trajectory out-
come, termed recovery, represents individuals who ini-
tially experience elevations in symptoms and distress,
followed by a gradual reduction and return to the popula-
tion norm. Finally, the delayed reaction category includes
individuals who initially show moderate (sub-threshold)
symptom levels after a potentially traumatic event, fol-
lowed by a gradual increase to above-threshold elevations
over time. These four prototypical outcome trajectories
and the estimated proportion of people in each category
as observed in previous studies are shown in Figure 1. It
should be noted that the percentages of people in each
category tends to vary depending on the severity and type
of trauma [33,36,37]. For example, Bonanno et al. [30]
examined the prototypical outcome trajectories of Hong
Kong patients who had recovered from severe acute
respiratory syndrome (SARS) and reported a higher per-
Figure 1 Hypothesized Prototypical Outcome Trajectories after a 
Stressful EventHo et al. BMC Cancer 2010, 10:279
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centage of people in the chronic dysfunction category
(42%) than in other previous studies.
Most previous studies have used a normative compari-
son approach that defines health and dysfunction on the
basis of established norms for the specified outcome
measure to define the outcome trajectories [34,38]. Pro-
totypical trajectories defined in this way are represented
graphically in Figure 1. The latent class growth curve
model has recently been used to classify people into these
outcome trajectories [30] although results similar to
those obtained under the normative comparison
approach were obtained.
The Present Study
The prospective longitudinal study reported in this paper
was aimed at investigating whether the cognitive style of
hope can predict prototypical psychological outcome tra-
jectories after HCRC genetic testing. In particular, we
hypothesized that high-hope HCRC genetic testing recip-
ients would have a higher tendency to show a resilience
outcome trajectory pattern than their low-hope counter-
parts. The current investigation makes several contribu-
tions to existing research. First, as the only study to have
applied the cognitive style of hope to HCRC genetic test-
ing, the findings could have important implications for
the psychosocial care of individuals undergoing HCRC
genetic testing. Furthermore, to the best of our knowl-
edge, no prior study has yet examined the prevalence of
the prototypical outcome trajectories following genetic
testing. Finally, this is one of the rare studies to have
employed the prototypical outcome trajectories to study
resilience among an Asian population [27].
Methods
Participants and Procedures
Seventy-six consecutive individuals offered genetic test-
ing by the Hereditary Gastrointestinal Cancer Registry
(the Registry) in Hong Kong between April 2003 and
August 2006 participated in this study after giving
informed consent. All of the subjects came from families
with proven HCRC syndromes, including familial ade-
nomatous polyposis (FAP) and hereditary non-polyposis
colorectal cancer (HNPCC). Among the 76 participants,
71 individuals (43 men and 28 women) from nine FAP
and 24 HNPCC families completed the study, including
39 mutation carriers (12 FAP and 27 HNPCC). There
were 27 (38.0%) subjects (15 men, 12 women) from FAP
families and 44 (62.0%) subjects (28 men, 16 women)
from HNPCC families. The mean age was 38.9 years ± 9.2
years (range: 21-66 years). Forty-eight (67.6%) subjects
were married , among whom 40 (56.3%) had one or more
children. There was no significant difference in personal
characteristics between FAP and HNPCC family mem-
bers.
The participants completed a package of psychological
inventories four times during the HCRC genetic testing
process: immediately before result disclosure (T1); two
weeks after result disclosure (T2); four months after
result disclosure (T3); and one year after result disclosure
(T4). The first assessment (T1) was conducted at the Reg-
istry on the day immediately before result disclosure. A
research assistant was available to answer participants'
questions. Later assessments (T2 - T4) were conducted at
the subjects' homes. Ethical approval was obtained from
the Institutional Review Board of Queen Mary Hospital,
Hong Kong.
Measures
Dispositional Hope - The 12-item Adult Trait Hope Scale
was rated on the basis of an 8-point Likert scale (1 = defi-
nitely false to 8 = definitely true) used to measure hope
according to the model of Snyder et al. [17]. A Hope Total
score is obtained by aggregating the scores for the 12
items. Because dispositional hope is a trait measure, it
was assessed only at T1. The Cronbach's alpha for the
total sample at T1 was 0.85.
Anxiety and Depression - The 14-item Chinese version
of the Hospital Anxiety and Depression Scale was used to
indicate negative emotions [39]. Two scores - HADS
Anxiety and HADS Depression- were derived from the
questionnaire. Severity of symptom was rated according
to a 4-point Likert scale. Higher scores correspond to
more symptoms of anxiety and depression, respectively.
The 7/8 normative cut-off points for HADS Anxiety and
HADS Depression were used to classify participants into
low (a score of below or equals to 7) or high (a score of
above or equals to 8) anxiety and depression, respectively
[39]. For the present sample, the Cronbach's ￿ values for
the HADS Anxiety ranged from 0.82 to 0.89 across the
four time points (T1 - T4) and those for the HADS
Depression from 0.82 to 0.72.
Data Analysis
Descriptive statistics were provided first and potential
syndrome-group (FAP versus HNPCC) and gender differ-
ences were examined. Pearson product-moment correla-
t i o n s  o f  t h e  va ri a b l e s  a t  T 1  w e r e  t h e n  a n a l yz ed  w h i c h
allowed us to examine the cross-sectional intercorrela-
tional relationships among the psychological variables.
The subjects were then classified into different psycho-
logical outcome trajectories according to the steps
described below (see next section). Finally, logistic
regression analyses were used to investigate whether dis-
positional hope at T1 could predict psychological out-
come trajectories after controlling for anxiety or
depression level at T1. Given that previous studies show
that mutation status (carrier versus non-carrier) is an
important factor affecting adjustment [7,8], the interac-Ho et al. BMC Cancer 2010, 10:279
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tion of hope and mutation status and the interaction of
T1 depression or anxiety and mutation status were also
entered into the regression equations.
Strategies to Establish the Psychological Outcome 
Trajectories
We used the normative comparison approach to create
longitudinal outcome trajectories for psychological func-
tioning using the HADS Anxiety or HADS Depression
score at two weeks (T2), four months (T3), and 12
months (T4) post-HCRC genetic testing as separate out-
come indicators. The following steps were employed to
create the outcome trajectories.
1. We used the 7/8 cut-off of the HADS to classify
each subject at each time point as a case (with a score
≥ 8) or a non-case (with a score ≤ 7) [39]. For example,
if a subject had a HADS Anxiety score of 9 at T2, then
he or she was classified as a HADS Anxiety case at T2.
If the same subject had a HADS Anxiety score of 3 at
T3, then he/she was considered to be a HADS Anxi-
ety non-case at T3.
2. We mapped all possible combinations of cases and
non-cases across the three post-genetic testing result
disclosure time points (i.e. two weeks, four months
and 12 months post-result disclosure).
3. We categorized participants into one of the four
prototypical outcome trajectories [33] using the fol-
lowing operational definitions: Resilience  was
assigned when the subject was a non-case at all three
time points; Chronic Dysfunction was assigned when
the subject was a case at all three time points; Recov-
ery was assigned when the subject was a case at T2
but became a non-case at both T3 and T4, or when he
or she was a case at both T2 and T3 but became a
non-case at T4; Delayed Dysfunction was assigned
when the subject was a non-case at T2 but became a
case at both T3 and T4 or when he or she was a non-
case at both T2 and T3 but became a case at T4. Oth-
ers included all combinations of cases and non-cases
across time points other than those described above.
Table 1 summarizes the criteria used in defining the
four prototypical outcome trajectories in this study.
Results
Intraclass correlation coefficient (ICC)
ICC(1) values of predictors at T1 and psychological indi-
c a t o r s  a t  T 2  w e r e  c a l c u l a t e d  t o  e x a m i n e  t h e  i n d e p e n -
dence of the data. All ICC(1) values were < 0.25 (range: 0
to 0.24) and met the criteria for independent measure-
ment[40].
Psychological characteristics
Due to the unequal group sizes, the powers of the analy-
ses undertaken to detect group differences in syndrome
type (FAP versus HNPCC) and mutation status (carrier
versus non-carrier) were low to modest, ranging from
0.10 to 0.51. The following results should be interpreted
with caution.
Table 2 shows the mean scores of the variables at each
time point. HNPCC subjects had a higher level of dispo-
sitional hope at T1 than FAP subjects (t(67) = -2.06, p =
0.04). No difference in the anxiety or depression level
between the FAP and HNPCC subjects was observed at
any time point. Independent sample t-tests were also
conducted to examine gender differences. No significant
difference for any variable was obtained at any time
points. However, subjects with a positive genetic test
result had higher HADS Anxiety scores at both T2 and
T4. We aggregated HNPCC and FAP subjects for subse-
quent analyses.
Correlation of Variables at Time 1
The correlation coefficients of variables at T1 are
depicted in Table 3 to show the cross-sectional relation-
ship of the variables examined in this study. Hope was
related to depression, but not to anxiety. Age had no rela-
tionship with the three psychological variables investi-
gated in this study.
Psychological Outcome Trajectories
The subjects were classified into different psychological
outcome trajectories using the method described previ-
ously. The results for HADS Anxiety and HADS Depres-
sion are first presented separately.
HADS Anxiety as an Outcome Indicator - The trajecto-
ries for anxiety are illustrated in Figure 2. The most prev-
alent was resilience, or stable low anxiety across time.
Approximately two-thirds of our subjects exhibited evi-
dence of this trajectory. Delayed reaction, which was
characterized by minimal anxiety at T1 and T2 and then a
steady increase in the anxiety levels to above the thresh-
old at T4, captured 15.9% of our subjects. The percent-
ages of subjects manifesting a chronic dysfunction
trajectory (8.7%) or a recovery trajectory (4.3%) were
lower. A small portion of the sample (4.3%) displayed evi-
dence of a variable pattern that could not be categorized
into any of the four prototypical patterns.
HADS Depression as an Outcome Indicator - The out-
come trajectories for depression are illustrated in Figure
3. Again, resilience (76.8%) was the most prevalent fol-
lowed by delayed reaction (13.0%). Interestingly, none of
the subjects exhibited a recovery trajectory when HADS
Depression was used as the outcome indicator. A rela-
tively small percentage of subjects were classified as hav-
ing chronic dysfunction (7.2%). A small portion of the
sample (2.9%) could not be classified in any of the proto-
typical trajectories.Ho et al. BMC Cancer 2010, 10:279
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Hope to Predict Resilience after HCRC Genetic Testing
Two logistic regressions were then conducted to test
whether hope is a reliable predictor of resilience among
recipients of HCRC genetic testing. Because very few
participants exhibited a recovery trajectory (n = 3 for
anxiety and n = 0 for depression), this outcome category
was excluded from the regression analyses. The delayed
reaction and chronic dysfunction trajectories were
obtained into a single non-resilience outcome trajectory
because of the small number of subjects in each of these
two categories. The dependent variable was therefore a
dichotomous outcome trajectory variable: resilience
(coded as "1") and non-resilience (coded as "2"). The first
logistic regression equation adopted HADs Anxiety as
the criterion variable for categorization of the outcome
trajectories, whereas the second used HADS Depression.
In both regression equations, the subject's gender (male
or female), syndrome group (FAP versus HNPCC), and
genetic test result (positive versus negative) were entered
in the first step. In step 2, either HADS Anxiety or HADS
Table 1: Operational Definition of the Four Prototypical Outcome Trajectories
Two weeks post-result disclosure (T2) Four months post- result disclosure (T3) One year post- result disclosure (T4)
Resilience Non-case Non-case Non-case
Chronic Case Case Case
Recovery Case Non-case Non-case
Case Case Non-case
Delay Non-case Case Case
Non-case Non-case Case
Table 2: Descriptive Statistics
FAP Mean (SD) HNPCC Mean (SD) t-value
Time 1 (Immediately before learning genetic result)
Hope 45.56 (7.05) 49.12 (6.97) -2.06*
Anxiety 4.26 (3.29) 4.98 (2.96) -0.95
Depression 3.26 (3.18) 4.23 (2.90) -1.32
Time 2 (2 weeks)
Anxiety 3.22 (3.61) 3.95 (3.02) - 0.92
Depression 2.37 (3.04) 307 (2.57) - 1.03
Time 3 (four weeks)
Anxiety 4.00 (3.50) 4.77 (4.12) - 0.79
Depression 2.67 (3.04) 2.81 (5.69) - 0.12
Time 4 (one year)
Anxiety 4.50 (3.37) 5.72 (3.73) -1.36
Depression 3.44 (2.85) 4.90 (3.53) -1.80
** p < 0.05Ho et al. BMC Cancer 2010, 10:279
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Depression and the Hope Total score at T1 were entered
together with the two interaction terms: Hope x Genetic
Testing Results and HADS Anxiety or HADS Depression
x Genetic Testing Results. The results of these analyses
are presented in Table 4. For both logistic regressions,
recipients' dispositional hope at pre-disclosure baseline
tended to be a significant individual predictor of resil-
ience (Anxiety: β = -0.11, p = 0.05; Depression: β = -0.25,
p < 0.05). Hence, dispositional hope may predict the resil-
ience of our HCRC genetic testing recipients after con-
trolling for demographic and medical information as well
as for mood status prior to test result disclosure.
Discussion
I n  t h i s  s t u d y ,  w e  u s e d  a  l o n g i t u d i n a l  d e s i g n  t o  a s s e s s
HCRC genetic testing recipients prospectively on four
occasions over a one year period. Our results advance our
understanding of the psychological consequences of
HCRC genetic testing in several ways. First, the longitudi-
nal design we employed is relatively uncommon among
cancer genetic studies and, to the best of our knowledge,
the present study is the first to use a prospective design to
investigate psychological outcomes of cancer genetic test-
ing among an Asian population. Second, this is the first
study to examine the prevalence of different longitudinal
outcome trajectories among recipients of HCRC genetic
Table 3: Correlates of Psychological Variables among FAP and HNPCC Subjects
1234
1. Hope Total * - 0.18 - 0.36** 0.13
2. HADS Anxiety * 0.65** 0.04
3. HADS Depression * 0.16
4. Age *
** p < 0.01
Figure 2 Outcome Trajectories of HADS Anxiety after HCRC Genetic Testing. (1) T1 = Immediately before disclosure of genetic testing result; T2 
= Two weeks post-result disclosure; T3 = Four months post-result disclosure; T4 = One year post-result disclosure. (2) A small portion of the sample 
(4.3%) evidenced a variable pattern that could not be categorized into one of the four prototypical patterns was not shown in the figure.Ho et al. BMC Cancer 2010, 10:279
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testing. None of the previous studies on HCRC genetic
testing has studied outcome trajectories. However,
research on these trajectories is becoming an important
area of investigation in the field of traumatology [30,33].
Our study provides timely data enabling comparison of
the experience of HCRC genetic testing recipients with
that of subjects affected by other stressful events. Third,
we examined the influence of dispositional hope, a con-
struct that has gained much attention in psychology in
recent years, to predict outcome trajectories. This
approach is unique among both hope and HCRC genetic
testing studies.
The prevalence of outcome trajectories observed in the
current study showed that a majority of the HCRC
genetic testing recipients were psychologically resilient
(66.7% for HADS Anxiety and 76.8% for HADS Depres-
sion); that is, these individuals exhibited little or no
depression and anxiety from pre-disclosure baseline until
one year after disclosure. Our results are consistent with
those of other studies showing that predictive genetic
testing has no severe psychological impact on its recipi-
ents [7,8]. Only a minority of our sample exhibited chron-
ically elevated symptoms (8.7% for HADS Anxiety and
7.2% for HADS Depression). A prior study reported that
the percentage of BRCA1/2 or HNPCC genetic suscepti-
bility testing recipients exhibiting an elevated level of
anxiety dropped from 29.3% at two weeks to 14.1% at six
months after disclosure of the results [6]. Our results sug-
gest that the percentage of recipients showing chronic
anxiety and depression levels is likely to drop even further
to around 7%-9% at 12 months. This result is consistent
with previous observations in Western countries, where
t yp i c a l l y  o n l y  5 %  t o  1 0 %  o f  pe o p l e  e x po s ed  t o  l o s s  o r
potential trauma tended to experience chronic psycho-
logical dysfunction [41], while the majority of individuals
observed in these studies tend to exhibit psychological
resilience [33]. A recent study on outcome trajectories
among Hong Kong patients who had recovered from
SARS showed that 35% of the sample displayed resilience,
and 42% exhibited chronic dysfunction. In comparison
with these SARS survivors, our sample of HCRC genetic
testing recipients showed a higher prevalence of resil-
ience and a lower prevalence of chronic dysfunction. Pre-
vious studies have suggested that the severity of the
stressful event is an important factor affecting the preva-
lence of outcome trajectories: individuals exposed to
extremely stressful events exhibited a higher prevalence
of psychopathology and a lower prevalence of resilience
in comparison with those who were exposed to low-stress
levels [31]. The high prevalence of resilience trajectories
and the low prevalence of chronic dysfunction trajecto-
ries in our study suggest that HCRC genetic testing
induces a milder level of stress in its subjects.
Figure 3 Outcome trajectories of HADS Depression after HCRC Genetic Testing. (1)T1 = Immediately before disclosure of genetic testing result; 
T2 = Two weeks post-result disclosure; T3 = Four months post-result disclosure; T4 = One year post-result disclosure. (2) A small portion of the sample 
(2.9%) evidenced a variable pattern that could not be categorized into one of the four prototypical patterns was not shown in the figure.Ho et al. BMC Cancer 2010, 10:279
http://www.biomedcentral.com/1471-2407/10/279
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Another finding is that 13%-15% of our subjects exhib-
ited a delayed reaction trajectory, i.e. they reported low
levels of anxiety and depression initially but their anxiety
and distress levels increased beyond the threshold at T3
or T4. The prevalence of delayed reaction trajectories in
this investigation is higher than that observed in previous
studies conducted in Western countries (5-10%) but is
similar to the 13% reported in a recent study among Hong
Kong SARS survivors [30]. It is possible that the percep-
tion of less support from the Registry on the anniversary
of genetic testing may have caused the elevated anxiety
level at T4. Similar elevated psychological distress
towards discharge after hospitalization has been reported
following other clinical procedures such as bone marrow
transplantation [42]. Another possibility is that the
HCRC genetic testing results may have a delayed effect
on the recipients. For recipients with positive results, the
long-term negative consequences of being mutation car-
riers, such as the inconvenience of regular lifelong medi-
cal surveillance and the potential for social
discrimination, may only become apparent a few months
after result disclosure. For those with negative testing
results, adverse psychological reactions such as feelings
of guilt for being a non-carrier in the family and commu-
nication issues among family members relating to the
testing results may only surface some time after result
disclosure [13]. However, the supposition that these fac-
tors may affect the prevalence of delayed reaction trajec-
tories is tentative and should be investigated in
independent studies.
Another objective of the present study was to examine
the role of hope [43,44] in affecting the psychological out-
come trajectories of HCRC genetic testing recipients.
Logistic regression analyses showed that even when the
depression and anxiety levels of the subjects at T1 were
statistically controlled, hope was still predictive of their
resilience trajectories. We believe that high-hope individ-
uals, when confronted with an adverse event such as
HCRC genetic testing, are better able to reprioritize their
goals in life, better able to generate alternative ideas about
how to achieve these goals and have higher levels of moti-
vation to actualize alternative pathways to them[43].
These attributes should be particularly relevant to the
adjustment of predictive genetic testing results.
The study has several limitations which should be men-
tioned. Because our sample size was relatively small, our
findings can be generalized only with caution. More
importantly, because we had to combine the delayed
reaction and chronic dysfunction groups into a single
non-resilience group in the logistic regression analysis,
we were prevented from investigating the predictive
power of disposition hope for each trajectory path. In
addition, the unequal group sizes of syndrome type and
mutation status also reduced the power of our analyses.
Furthermore, other personality measures (e.g. neuroti-
cism) and confounding variables not included in the
regression analysis may have influenced the results. For
example, we did not measure life events, and it is possible
that the participants' reports on their depression and anx-
iety levels one year after genetic testing have been
affected by other factors in their lives. Independent stud-
Table 4: Summary of Logistic Regression Analysis for Variables Predicting Resilience versus Other Outcome Trajectories 
for HADS Anxiety and HADS Depression
Resilience: HADS Anxiety Resilience: HADS Depression
Predictor BS E  B e B B SE B eB
Final Step
Gender 0.33 0.71 1.39 -0.26 0.96 0.78
Syndrome Group 0.93 0.71 1.69 2.48 1.22 11.92
Genetic Testing Results 0.62 5.15 1.85 -8.50 6.91 0.00
HADS Anxiety or HADS Depression at T1 0.22 0.17 1.71 0.56* 0.25 1.72
Hope Total at T1 - 0.11a 0.06 0.90 - 0.25* 0.11 0.78
Hope x Genetic Testing Results -0.03 0.11 0.97 -0.05 0.34 0.95
HADS Anxiety at T1 x Genetic Testing Results -0.03 0.21 0.97 0.18 0.14 1.12
Constant 1.61 3.01 4.98 3.74 4.89 42.41
χ2 16.53* 35.86**
df 77
Overall Percentage of Correct Classification 74.2% 85.5%
Note: eB = exponentiated B. Gender coded as 0 for male and 1 for female. Syndrome Group coded as 0 for FAP and 1 for HNPCC. Genetic testing 
results coded as 0 = positive; 1 = negative; ap = 0.05; *p < 0.05; **p < 0.01.Ho et al. BMC Cancer 2010, 10:279
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ies with a larger sample size and a more even distribution
of group sizes could be carried out in future to examine
whether our present findings can be replicated.
Conclusions
It is possible that high-hope individuals adjust more read-
ily to the results of HCRC genetic testing than their low-
hope counterparts. Systematic and empirically-supported
hope-based training is now available to increase individu-
als' hopefulness [45]. In addition to educating subjects
about colorectal cancer and genetic testing, hope-based
training can be incorporated into genetic counselling
programs for individuals undergoing HCRC genetic test-
ing. Systematic outcome studies should be conducted to
examine the effectiveness of such hope-based interven-
tion programs which should ideally be provided during
the waiting period for genetic testing results.
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